Answers are grounded in this paper and cite their sources.
Background: Glioblastoma (GBM) is the most aggressive primary malignant brain tumor in adults, characterized by a profoundly immunosuppressive tumor microenvironment (TME) dominated by tumor-associated microglia and macrophages (TAMs). Severe metabolic bottlenecks within the hypoxic GBM core impose chronic proteostatic stress, engaging the Unfolded Protein Response (UPR). While traditionally viewed as cell-autonomous survival circuits, emerging evidence indicates that UPR sensors actively drive myeloid cell infiltration, metabolic rewiring, and immune evasion. This systematic review evaluates how ER stress and UPR networks operate within microglia, TAMs, and myeloid-derived suppressor cells (MDSCs) to shape GBM progression. Methods: Following PRISMA guidelines, a comprehensive search of PubMed and Scopus was conducted. Studies investigating ER stress or UPR pathways specifically within microglial, TAM, or myeloid populations in the context of glioblastoma were included. Methodological quality and risk of bias were assessed using a customized robvis -compatible evaluation framework across four core domains. Results: A total of 34 publications met the predefined eligibility criteria, comprising primary research studies and secondary review articles. The included literature was synthesized qualitatively, with primary research findings distinguished from evidence and interpretations reported in secondary reviews. The synthesis indicates that UPR signaling may contribute to glioblastoma microenvironmental remodeling and immunosuppressive myeloid-cell functions, although its effects appear to depend on the specific signaling branch, cellular context, and experimental model. The PERK-eIF2α-ATF4 axis promotes myeloid chemotaxis via CSF-1 and CCL2 while driving GLUT1-mediated glycolysis and histone lactylation (K_la) at the IL-10 promoter to suppress CD8 + T-cell function. Concurrently, the IRE1α-XBP1s axis functions as an immunometabolic switch that regulates UBE2D3/NF-kB signaling, lipid droplet accumulation, and immunosuppressive cytokine production. Furthermore, cell-surface GRP78 (csGRP78) and Transmissible ER Stress (TERS) via extracellular vesicles horizontally propagate pro-tumoral M2-like polarization. Preclinical interventions targeting UPR sensors (e.g., iPERK, DDRGK1/UFMylation inhibition) combined with immunotherapies (such as CD47-SIRPα blockade or sonodynamic immunogenic cell death) successfully reverse immunosuppressive phenotypes and inhibit tumor recurrence. Conclusion: Endoplasmic reticulum stress and UPR signaling within the GBM myeloid compartment critically drive tumor progression and immune escape. Targeting selected UPR pathways in combination with macrophage-directed immunotherapeutic approaches represents a potential therapeutic strategy that warrants further preclinical validation and clinical investigation.
No takes yet. Share an insight, caveat, or question.
João Guerreiro (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: